SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-017105
Filing Date
2021-07-16
Accepted
2021-07-16 17:37:41
Documents
1
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8308
  Complete submission text file 0001493152-21-017105.txt   9714
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
KING STEVEN W (Reporting) CIK: 0001244106 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 211096367